The importance of Hepatocyte Growth Factor Receptor signaling in normal and pathological conditions is well established. Poor regulation of Hepatocyte Growth Factor Receptor signaling underlies several human cancers including invasive breast, gastrointestinal and hepatic carcinomas, correlating closely with metastatic tendency, angiogenesis and poor prognosis. Endocytic studies on many cell surface receptors suggest that receptor signaling and trafficking function cooperatively to determine signaling endpoints in vivo. In this context increased metastasis and angiogenesis are distinguishing features of Hepatocyte Growth Factor Receptor signaling suggesting that the receptor itself is subject to tight regulation by specific signaling cascades and endocytic mechanisms. Activation of Hepatocyte Growth Factor Receptor by ligand binding triggers receptor internalization and eventual down regulation. However it is presently unclear how Hepatocyte Growth Factor Receptor signaling is coupled to this endocytic response and the subsequent cellular phenotypes. In this exploratory R21 proposal we will test the hypothesis that signaling from the Hepatocyte Growth Factor Receptor regulates its own internalization. Our preliminary studies show that the Hepatocyte Growth Factor Receptor is internalized exclusively through clathrin-coated pits and that distinct subsets of downstream signaling adaptors regulate this process. The exploratory studies proposed in this R21 will further define the requirement of distinct receptor-adaptor interactions for receptor internalization (Aim 1) and delineate their mechanism of action, with particular focus on recruitment of receptor into coated pits, vesicle budding and transport via the early endosomes (Aim 2). Achieving these aims will provide the necessary tools and approaches for future studies aimed at delineating the molecular mechanisms coupling Hepatocyte Growth Factor Receptor trafficking with its signaling properties and provide data that may be useful in the development of novel therapeutic strategies. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21CA112605-01
Application #
6866036
Study Section
Gastrointestinal Cell and Molecular Biology Study Section (GCMB)
Program Officer
Ault, Grace S
Project Start
2005-06-01
Project End
2007-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
1
Fiscal Year
2005
Total Cost
$129,860
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Neurosciences
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Gao, Xiu; Lorinczi, Marta; Hill, Kristen S et al. (2009) Met receptor tyrosine kinase degradation is altered in response to the leucine-rich repeat of the Listeria invasion protein internalin B. J Biol Chem 284:774-83
Li, Ning; Hill, Kristen S; Elferink, Lisa A (2008) Analysis of receptor tyrosine kinase internalization using flow cytometry. Methods Mol Biol 457:305-17
Sheth, Payal R; Hays, John L; Elferink, Lisa A et al. (2008) Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation. Biochemistry 47:4028-38
Li, Ning; Lorinczi, Marta; Ireton, Keith et al. (2007) Specific Grb2-mediated interactions regulate clathrin-dependent endocytosis of the cMet-tyrosine kinase. J Biol Chem 282:16764-75
Strick, David J; Elferink, Lisa A (2005) Rab15 effector protein: a novel protein for receptor recycling from the endocytic recycling compartment. Mol Biol Cell 16:5699-709